Maintaining over time clinical performance targets on anaemia correction in unselected population on chronic dialysis at 20 Italian centres. Data from a retrospective study for a clinical audit

BMC Nephrology

Volumn 10, Issue 1, 2009, Pages

  Soffritti, Silvia ^a   Russo, Giorgia ^a   Cantelli, Stefano ^a   Gilli, Giuseppe ^a   Catizone, Luigi ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; ERYTHROPOIETIN; FERRITIN; FOLINATE CALCIUM; HEMOGLOBIN; IRON; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL EVALUATION; DIABETIC PATIENT; DRUG DOSE REGIMEN; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MYELOMA; NEOPLASM; PARAMETER; PERFORMANCE MEASUREMENT SYSTEM; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; TRANSFERRIN BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ITALY; METHODOLOGY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TIME; TREATMENT OUTCOME;

AGED; ANEMIA; CLINICAL AUDIT; ERYTHROPOIETIN; FEMALE; HUMANS; ITALY; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 72849137259     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-10-33     Document Type: Article

References (33)

1. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. F Locatelli P Aljama P Brny B Canaud F Carrera KU Eckardt WH Hörln IC Macdougal A Macleod S Cameron, Nephrol Dial Transplant 2004 19 Suppl 2 i1 47 http://ndt.oxfordjournals.org/content/vol19/ suppl-2/index.dtl 15206425 10.1093/ndt/gfh1032 (Pubitemid 38786779)
2. OPTA: Optimal treatment of anaemia in patients with Chronic kidney disease (CKD). WH Hrl Y Vanrenterghem P Aljama P Brunet R Brunkhorst L Gesualdo I Macdougall C Wanner B Wikstrm, Nephrol Dial Transplant 2007 22 Suppl 3 ii20 iii26 10.1093/ndt/gfm017
3. Guidelines for the treatment of anemia in chronic renal failure. G Triolo D Brancaccio C Canavese S Carozzi B Cianciaruso G Panzetta A Piccoli A Albertazzi M Amato G Cancarini L Del Vecchio G Maschio DA Procaccini C Spinelli, G Ital Nefrol 2003 Suppl 24 61 82 http://www.sin-italy.org/pdf/linee-guida/ 2003-LG-anemia.pdf 14666504
4. Hemoglobin targets for chronic kidney disease: guideline from the Italian Society of Nephrology. C Canavese GF Strippoli M Bonomini G Triolo, G Ital Nefrol 2007 24 Suppl 37 99 106 17347959
5. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study(DOPPS). F Locatelli RL Pisoni C Combe J Bommer VE Andreucci L Piera R Greenwood HI Feldman FK Port PJ Held, Nephrol Dial Transplant 2004 19 121 132 10.1093/ndt/gfg458 14671047 (Pubitemid 38072623)
6. Hemoglobin and haematocrit targets for the anaemia of chronic kidney disease. GFM Strippoli SD Navaneethan JC Craig, Cochrane Database of Systematic Reviews 2006 4 D003967 http://mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD003967/frame.html
7. Mortality and target Hemoglobin concentrations in anaemic patients with chronic kidney disease treated with Erythropoietin: a meta-analysis. A Phrommintikul SJ Haas M Elsik H Krum, Lancet 2007 369 381 8 10.1016/S0140- 6736(07)60194-9 17276778
8. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. KDOQI, Am J Kidney Dis 2006 47 Suppl 3 11 145
9. CARI. http://www.cari.org.au/guidelines.php
10. Anaemia management in people with chronic kidney disease. National Collaborating Centre for Chronic Conditions, Royal College of Physicians 2006 http://www.nice.org.uk/CG039fullguideline 10.1038/ki.2008.270
11. Clinical Practice Guidelines for evidence-based use of erythropoietic-stimulating agents. ML Moist RN Foley BJ Barrett F Madore TC White SW Klarenbach BF Culleton M Tonelli BJ Manns, Kidney International 2008 74 Suppl 110 12 S18 10.1038/ki.2008.270
12. Evidence and implications of Hemoglobin cycling in anaemia Management. S Fishbane JS Berns, Nephrol Dial Transplant 2007 22 2129 2132 10.1681/ASN.2004080689 17595177
13. Impact of Hemoglobin variability in haemodialysis patients receiving erythropoiesis stimulating agents for the management of renal anaemia. IC Macdougall P Wilson A Roche, J Am Soc Nephrol 2005 16 899A PUB541 10.1681/ASN.2004080689 (Pubitemid 41710300)
14. Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. JP Ebben DT Gilbertson RN Foley AJ Collins, Clin J Am Soc Nephrol 2006 1 1205 1210 10.2215/CJN.01110306 17699349
15. Effect of variability in anemia management on Hemoglobin outcomes in ESRD. E Lacson Jr N Ofsthun JM Lazarus, Am J Kidney Dis. 2003 41 1 111 124 10.1053/ajkd.2003.50030 12500228 10.1053/ajkd.2003.50030
16. The Optimal Hemoglobin in Dialysis Patients -A Critical Review. AK Singh S Fishbane, Semin Dial 2008 21 1 6 18251947 10.1111/j.1525-139X.2007.00329.x
17. Predictors of Erythropoietin responsiveness in chronic hemodialysis patients. M Tonelli PG Blake N Muirhead, ASAIO J 2001 47 82 85 10.1097/00002480-200101000-00017 11199321
18. Hemoglobin cycling in hemodialysis patients treated with recombinant human Erythropoietin. S Fishbane JS Berns, Kidney Int 2005 68 1337 1343 10.1046/j.1523-1755.2003.00229.x 16105069
19. Hemoglobin variability in epoetin-treated hemodialysis patients. JS Berns H Elzein RI Lynn S Fishbane IS Meisels PB Deoreo, Kidney Int 2003 64 1514 1521 10.1097/01.ASN.0000026611.07106.A7 12969173
20. Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. AK Cheung G Yan T Greene JT Daugirdas JT Dwyer NW Levin DB Ornt G Schulman G Eknoyan, J Am Soc Nephrol 2002 13 2345 2352 10.1097/01.ASN.0000026611.07106.A7 12191979
21. Hemoglobin variability: impact on anemia management practices. R Breiterman-White, Nephrol Nurs J 2003 30 456 459 10.1111/j.1525-139X.2007.00329. x 14533525
22. The Optimal Hemoglobin in Dialysis Patients -A Critical Review. AK Singh S Fishbane, Semin Dial 2008 21 1 6 10.1093/ndt/gfm374 18251947
23. Time to target Hemoglobin concentration (11 g/dl) risk of hospitalization and mortality among incident dialysis patients. A Ishani H Guo DT Gilbertson J Liu S Dunning AJ Collins RN Foley, Nephrol Dial Transplant 2007 22 2247 55 10.1046/j.1523-1755.2003.00937.x 17597082
24. The effects of higher Hemoglobin levels on mortality and hospitalization in hemodialysis patients. N Ofsthun J Labrecque E Lacson M Keen JM Lazarus, Kidney Int 2003 63 1908 14 10.1093/ndt/gfm845 12675871
25. Association between number of months below K/DOQI Hemoglobin target and risk of hospitalization and death. A Ishani CA Solid ED Weinhandl DT Gilbertson RN Foley AJ Collins, Nephrol Dial Transplant 2008 23 1682 9 10.2215/CJN.01110306 18065802
26. Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. JP Ebben DT Gilbertson RN Foley AJ Collins, Clin J Am Soc Nephrol 2006 1 1205 10 10.2215/CJN.01610407 17699349
27. Hemoglobin level variability: associations with mortality. DT Gilbertson JP Ebben RN Foley ED Weinhandl BD Bradbury AJ Collins, Clin J Am Soc Nephrol 2008 3 133 8 18045862 10.2215/CJN.01610407
28. Hemoglobin variability and mortality in ESRD. W Yang RK Israni SM Brunelli MM Joffe S Fishbane HI Feldman, J Am Soc Nephrol 2007 18 12 3164 70 10.1681/ASN.2007010058 18003781
29. History adjusted marginal structural analysis of the association between Hemoglobin variability and mortality among chronic hemodialysis patients. SM Brunelli MM Joffe RK Israni W Yang S Fishbane JS Berns HI Feldman, Clin J Am Soc Nephrol 2008 3 777 82 18337553 10.2215/CJN.04281007
30. Stability of target Hemoglobin levels during the first year of epoetin treatment in patients with chronic kidney disease. L De Nicola G Conte P Chiodini B Cianciaruso A Pota V Bellizzi G Tirino D Avino F Catapano R Minutolo, Clin J Am Soc Nephrol 2007 2 938 46 10.2215/CJN.01690407 17724278
31. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study. LC Plantinga NE Fink BG Jaar JH Sadle NW Levin J Josef Coresh MJ Klag R Neil NR Powe, BMC Health Services Research 2007 7 5 10.1186/1472-6963-7-5 17212829
32. Focus on achieving and maintaining target Hemoglobin levels in dialysis patients. Preliminary report on 20 italian dialysis centres data. S Soffritti S Cantelli G Russo G Gilli F Fabbian L Catizone, [SaP331] ERA ETDA, Archive Meeting Abstracts 2002 2007 http://www.abstracts2view.com/era/authorindex.php
33. Guidelines audit may overcome disparities in health care: experience of an Italian region. M Salomone C Canavese D Bergamo Z Hollo D Damiani S Maffei R Fenoglio F Bermond V Cantaluppi M Quaglia G Triolo, J Nephrol 2006 19 296 302 16874688